Literature DB >> 19250277

Immune characterization of an individual with an exceptionally high natural killer T cell frequency and her immediate family.

A C Chan1, L Serwecinska, A Cochrane, L C Harrison, D I Godfrey, S P Berzins.   

Abstract

Natural killer T cells (NKT) are a regulatory subset of T lymphocytes whose frequency in peripheral blood is highly variable within the human population. Lower than normal NKT frequencies are associated with increased predisposition to a number of diseases, including type 1 diabetes and some forms of cancer, raising the possibility that an increased frequency may be protective. However, there is little or no understanding of how high NKT frequencies arise or, most importantly, whether the potential exists to boost and maintain NKT levels for therapeutic advantage. Here, we provide a detailed functional and phenotypic characterization of the NKT compartment of a human donor with NKT levels approximately 50 times greater than normal, including an analysis of NKT in her immediate family members. The study focuses upon the characteristics of this donor and her family, but demonstrates more broadly that the size and flexibility of the NKT niche is far greater than envisioned previously. This has important implications for understanding how the human NKT compartment is regulated, and supports the concept that the human NKT compartment might be expanded successfully for therapeutic benefit.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19250277      PMCID: PMC2759471          DOI: 10.1111/j.1365-2249.2009.03888.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression.

Authors:  Chang H Kim; Eugene C Butcher; Brent Johnston
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

2.  The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion.

Authors:  Michael T Wilson; Cecilia Johansson; Danyvid Olivares-Villagómez; Avneesh K Singh; Aleksandar K Stanic; Chyung-Ru Wang; Sebastian Joyce; Mary Jo Wick; Luc Van Kaer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

3.  CD1d-restricted NKT cells: an interstrain comparison.

Authors:  K J Hammond; D G Pellicci; L D Poulton; O V Naidenko; A A Scalzo; A G Baxter; D I Godfrey
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment.

Authors:  Johan K Sandberg; Nina Bhardwaj; Douglas F Nixon
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

5.  Testing the NKT cell hypothesis of human IDDM pathogenesis.

Authors:  Peter T Lee; Amy Putnam; Kamel Benlagha; Luc Teyton; Peter A Gottlieb; Albert Bendelac
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 6.  NKT cells: potential targets for autoimmune disease therapy?

Authors:  K J L Hammond; D I Godfrey
Journal:  Tissue Antigens       Date:  2002-05

Review 7.  Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity.

Authors:  S Brian Wilson; Terry L Delovitch
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

8.  Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

Authors:  Shin-ichiro Fujii; Kanako Shimizu; Mitchell Kronenberg; Ralph M Steinman
Journal:  Nat Immunol       Date:  2002-08-05       Impact factor: 25.606

9.  Distinct functional lineages of human V(alpha)24 natural killer T cells.

Authors:  Peter T Lee; Kamel Benlagha; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.

Authors:  Jenny E Gumperz; Sachiko Miyake; Takashi Yamamura; Michael B Brenner
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  13 in total

1.  Genetic control of murine invariant natural killer T-cell development dynamically differs dependent on the examined tissue type.

Authors:  Y-G Chen; S-W Tsaih; D V Serreze
Journal:  Genes Immun       Date:  2011-09-22       Impact factor: 2.676

Review 2.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

Review 3.  Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.

Authors:  Mary Speir; Ian F Hermans; Robert Weinkove
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

Review 4.  Presumed guilty: natural killer T cell defects and human disease.

Authors:  Stuart P Berzins; Mark J Smyth; Alan G Baxter
Journal:  Nat Rev Immunol       Date:  2011-02       Impact factor: 53.106

5.  Lack of anti-tumour reactivity despite enhanced numbers of circulating natural killer T cells in two patients with metastatic renal cell carcinoma.

Authors:  F A Vyth-Dreese; J Sein; W van de Kasteele; T A M Dellemijn; C van den Bogaard; W J Nooijen; G C de Gast; J B A G Haanen; A Bex
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

6.  Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.

Authors:  Yanni Zhu; Drake J Smith; Yang Zhou; Yan-Ruide Li; Jiaji Yu; Derek Lee; Yu-Chen Wang; Stefano Di Biase; Xi Wang; Christian Hardoy; Josh Ku; Tasha Tsao; Levina J Lin; Alexander T Pham; Heesung Moon; Jami McLaughlin; Donghui Cheng; Roger P Hollis; Beatriz Campo-Fernandez; Fabrizia Urbinati; Liu Wei; Larry Pang; Valerie Rezek; Beata Berent-Maoz; Mignonette H Macabali; David Gjertson; Xiaoyan Wang; Zoran Galic; Scott G Kitchen; Dong Sung An; Siwen Hu-Lieskovan; Paula J Kaplan-Lefko; Satiro N De Oliveira; Christopher S Seet; Sarah M Larson; Stephen J Forman; James R Heath; Jerome A Zack; Gay M Crooks; Caius G Radu; Antoni Ribas; Donald B Kohn; Owen N Witte; Lili Yang
Journal:  Cell Stem Cell       Date:  2019-09-05       Impact factor: 24.633

7.  NKT Cell Subsets Can Exert Opposing Effects in Autoimmunity, Tumor Surveillance and Inflammation.

Authors:  Rachael Viale; Randle Ware; Igor Maricic; Varun Chaturvedi; Vipin Kumar
Journal:  Curr Immunol Rev       Date:  2012-11-01

8.  A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.

Authors:  S-W Tsaih; M Presa; S Khaja; A E Ciecko; D V Serreze; Y-G Chen
Journal:  Genes Immun       Date:  2015-02-05       Impact factor: 2.676

Review 9.  Regulation of NKT Cell Localization in Homeostasis and Infection.

Authors:  Drew Slauenwhite; Brent Johnston
Journal:  Front Immunol       Date:  2015-05-27       Impact factor: 7.561

10.  Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NKT cells following chlamydial genital infection.

Authors:  Janina Jiang; Ouafae Karimi; Sander Ouburg; Cheryl I Champion; Archana Khurana; Guangchao Liu; Amanda Freed; Jolein Pleijster; Nora Rozengurt; Jolande A Land; Helja-Marja Surcel; Aila' Tiitinen; Jorma Paavonen; Mitchell Kronenberg; Servaas A Morré; Kathleen A Kelly
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.